Silhouette
Upgrade to view details

Christopher E. Hopkins

Knudra Diagnostics

Message

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
SBIR Phase II: A Platform for Anthelmintic Drug Discovery using Genome-modified C. elegans
Knudra Diagnostics
Firm POC
NSF 2 $750K 02/27/15 02/28/17
SBIR Phase I: A Platform for Anthelmintic Drug Discovery using DAF-12 as a Novel Target
Knudra Diagnostics
Principal Investigator
NSF 1 $150K 01/01/13 12/31/13
SBIR Phase I: Biosensors to Detect and Characterize Genotoxins
Knudra Diagnostics
Principal Investigator
NSF 1 $150K 01/01/12 12/31/12